The time has come to stop letting the HERS tale wag the dogma

Circulation

Volumn 104, Issue 19, 2001, Pages 2256-2259

  Mendelsohn, Michael E ^a   Karas, Richard H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Editorials; Hormones; Risk factors; Trials; Women

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; AGED; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY RISK; EDITORIAL; FEMALE; FOLLOW UP; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0035818532     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/circ.104.19.2256     Document Type: Editorial

References (33)

1. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women
2. Hormone therapy to prevent disease and prolong life in postmenopausal women
3. Postmenopausal estrogenand progestin use and the risk of cardiovascular disease
4. Postmenopausal hormone therapy and mortality
5. Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
6. Experts advise against hormones for women's hearts
7. Hormones don't help heart, group now advises
8. Heart Association switches its stance on use of estrogen
9. Hormone, heart link in doubt
10. Research casts doubt on HRT's heart benefits
11. Hormones don't protect women from heart disease, study says
12. HRT may not protect heart as thought
13. Hormone therapy's bumpy ride
14. No hormones for sick hearts
15. A heart-to-heart on HRT: Doctors worry new advisory could lead to confusion
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, treatment of high blood cholesterol in adults (Adult Treatment Panel III)
17. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
18. Race and sex differences in the management of coronary artery disease
19. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
20. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
21. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients
22. A positive family history of premature coronary artery disease is associated with impaired endothelium-dependent coronary blood flow regulation
23. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study: A prospective, observational study
24. Hormone replacement therapy and incidence of acute myocardial infarction: A population-based nested case-control study
25. Hormone replacement therapy and in-hospital survival after myocardial infarction in postmenopausal women
26. Mechanisms of disease: The protective effects of estrogen on the cardiovascular system
27. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice
28. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis